Amyris
Amyris, Inc. is a biotechnology company that specializes in creating microbial strains to produce high-value ingredients from renewable, plant-sourced sugars. Utilizing its industrial synthetic biology platform, Amyris engineers microbes to convert these sugars into a variety of products, including cosmetics, flavors, fragrances, solvents, lubricants, and healthcare items. The company operates under several trademarks, including Amyris, Biofene, and Biossance, and focuses on providing sustainable alternatives to petroleum-sourced products. Additionally, Amyris collaborates with organizations such as the Infectious Disease Research Institute to advance vaccine development, including efforts related to COVID-19. Founded in 2003 and headquartered in Emeryville, California, Amyris generates revenue through product sales, licensing, royalties, and collaborative research initiatives, with a significant portion of its business conducted in the United States.
OLIKA is redesigned personal care staples starting with hand sanitizer.
Draths Corporation is building a next generation chemical company focused on manufacturing biobased materials used in everyday products. The company’s products, rooted in its platform technology, enable nylons, plastics, paints, resins, and other materials currently made using petroleum-based chemicals to be manufactured from renewable feedstocks.
This breakthrough is accomplished through environmentally friendly and economical processes, allowing reduced carbon footprints without absorbing the higher costs generally associated with renewable initiatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.